New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
InterCure Ltd.
INCR
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

60M

Drug Manufacturers - Specialty & Generic

1.31USD
Shape-0.02 ( -1.50%)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

204%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

65%

Quote Panel

Shape
Updated November 14, 2024
1W -14.94 % 1M -28.02 % 3M -30.32 % 1Y 3.15 %

Key Metrics

Shape
  • Market Cap

    59.95M


  • Shares Outstanding

    45.77M


  • Share in Float

    25.67M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    1.31


  • Average Volume

    29756


  • Beta

    0.033


  • Range

    1.06-3.72


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.intercure.co


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.83x

P/S Ratio

0.51x

P/B Ratio

0.3

Debt/Equity

-24.1%

Net Margin

$-0.4

EPS

How INCR compares to sector?

P/E Ratio

Relative Strength

Shape

INCR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1B

Shape1851%

2024-Revenue

0

$124M

Shape-1817%

2024-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Canaccord Genuity

upgrade

Previous: Not converted

2022-05-17

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

-17%

0.1
vs 0.12

Q3.22

arrow
arrow

+600%

0.05
vs -0.01

Q4.22

arrow
arrow

+316%

0.05
vs -0.02

Q1.23

arrow
arrow

+150%

0.01
vs -0.02

Q2.23

arrow
arrow

-70%

0.03
vs 0.1

Q3.23

arrow
arrow

N/A

0.05
vs 0.05

Q4.23

arrow
arrow

N/A

-0.21
vs 0.05

Q1.24

arrow
arrow

-59%

0
vs 0.01

Q2.24

arrow
arrow

-87%

0
vs 0.03

Q3.24

arrow
arrow

+11573%

5.84
vs 0.05

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

+111%

95.3M  vs 45.2M

Q3.22

arrow
arrow

+63%

100.6M  vs 61.7M

Q4.22

arrow
arrow

+33%

105.6M  vs 79.7M

Q1.23

arrow
arrow

+22%

106.2M  vs 87.2M

Q2.23

arrow
arrow

+8%

102.4M  vs 95.3M

Q3.23

arrow
arrow

-27%

73.5M  vs 100.6M

Q4.23

arrow
arrow

-30%

73.5M  vs 105.6M

Q1.24

arrow
arrow

-41%

62.9M  vs 106.2M

Q2.24

arrow
arrow

-39%

62.9M  vs 102.4M

Q3.24

arrow
arrow

-3%

71.5M  vs 73.5M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+1%

0.01
vs 0.03

Q4.22

arrow
arrow

+1%

0.01
vs 0.01

Q1.23

arrow
arrow

+0%

0
vs 0.01

Q2.23

arrow
arrow

+1%

0.01
vs 0

Q3.23

arrow
arrow

-7%

-0.07
vs 0.01

Q4.23

arrow
arrow

-7%

-0.07
vs -0.07

Q1.24

arrow
arrow

+0%

0
vs -0.07

Q2.24

arrow
arrow

+0%

0
vs 0

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

18

18
vs 16

13%

Q4.22

arrow
arrow

16

16
vs 18

-11%

Q1.23

arrow
arrow

18

18
vs 16

13%

Q2.23

arrow
arrow

19

19
vs 18

6%

Q3.23

arrow
arrow

22

22
vs 19

16%

Q4.23

arrow
arrow

18

18
vs 22

-18%

Q1.24

arrow
arrow

20

20
vs 18

11%

Q2.24

arrow
arrow

20

20
vs 20

NA

Earnings Growth

Latest News